Localization of smoothelin in avian smooth muscle and identification of a vascular-specific isoform  by Wehrens, X.H.T. et al.
FEBS 18352 FEBS Letters 405 (1997) 315-320 
Localization of smoothelin in avian smooth muscle and identification of 
a vascular-specific isoform 
X.H.T. Wehrensa, B. Miesb, M. Gimonab, F.C.S. Ramaekersa, G.J.J.M. Van Eysa, 
J.V. Smallb<* 
0Department of Molecular Cell Biology and Genetics, University Maastricht, P. O. Box 616, 6200 MD Maastricht, The Netherlands 
h Institute of Molecular Biology, Austrian Academy of Sciences, Billrothstrasse 11, A-5020 Salzburg, Austria 
Received 3 February 1997 
Abstract Smoothelin is a smooth muscle-specific protein of 
minor abundance first identified via a monoclonal antibody 
obtained using an avian gizzard extract as antigen. Dual 
labelling of ultrathin sections with antibodies to smoothelin 
together with antibodies to other smooth muscle proteins showed 
that smoothelin was co-distributed with filamin and desmin in the 
cytoskeleton domain of the smooth muscle cell. From the finding 
that smoothelin, unlike desmin, was readily extracted by Triton 
X-100 as well as under conditions that solubilized myosin, pVactin 
and filamin, we conclude that smoothelin is most likely 
associated with the actin cytoskeleton. Western blot analysis of 
gizzard smooth muscle tissue revealed an immunoreactive protein 
band with an apparent molecular weight of 59 kDa that 
separated into 3^1 isolated variants, while avian vascular muscle 
showed a polypeptide band of 95 kDa. These results point to the 
presence of specific isoforms in visceral and vascular smooth 
muscles. The 59 kDa isoform was shown to be distinct from the 
60 kDa filamin-binding protein, described by Maekawa and 
Sakai (FEBS Lett. 221, 68-72, 1987). As compared to other 
smooth muscle markers, such as calponin and SM22, smoothelin 
appeared very late during differentiation in the chick gizzard, on 
about the 18th embryonic day. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Smooth muscle cells show a marked plasticity in their state 
of differentiation, both in vivo and in vitro (reviewed in [1]). 
This modulat ion of phenotype may play a leading role in 
lesions of the blood vessel wall implicating smooth muscle 
cells in processes leading to vascular disease [1]. However, 
progress in understanding the role of smooth muscle in such 
phenomena has been hampered in part by a lack of markers 
for different stages of smooth muscle cell differentiation. 
Proteins characteristic of smooth muscle phenotype include 
smooth muscle myosin, metavinculin, heavy caldesmon and 
the smooth muscle actins (see review by [2]), as well as 
SM22 ([3]). These different protein constituents appear pro-
gressively during differentiation with the expression of myosin 
and caldesmon preceding that of calponin and SM22 ([1-3]). 
More recently, van der Loop et al. [4] identified a protein, 
designated smoothelin, via a monoclonal antibody raised 
against a chicken gizzard extract, whose expression appeared 
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to be restricted to highly differentiated smooth muscle cells. 
The protein, with an apparent molecular weight of 59 kDa, 
was found to be present in all vertebrate classes. The c D N A 
encoding for this protein has been cloned and sequenced and 
its putative primary structure has been deduced. To gain fur-
ther insight into the possible function of smoothelin we under-
took studies to determine its subcellular localization as well as 
its temporal appearance in gizzard smooth muscle cells. As we 
show, this protein is a minor component of the smooth muscle 
cell cytoskeleton that appears conspicuously late during differ-
entiation. A high molecular weight variant of smoothelin, 
which is specifically expressed in avian vascular smooth 
muscle, is also described. 
2. Materials and methods 
2.1. Tissues and frozen sections 
Freshly excised chicken gizzard from adult chicken was placed on 
ice and allowed to cool for at least 30 min. Thin ( ~ 1 mm) radial 
slices were cut from the main muscle layer using a razor blade, sep-
arated from the gizzard and transferred into cold cytoskeleton buffer 
(CB [5]). Narrow strips were then teased out of the slices and placed 
in a fixative containing 3% paraformaldehyde and 0.05% glutaralde-
hyde in CB for 5 min at room temperature. Alternatively, the slices 
were fixed directly in the same mixture and thin strips teased out after 
fixation. Subsequently the strips were washed several times in CB, 
followed by treatment with sodium borohydride (1.0 mg/ml) in the 
same buffer, for 3x10 min on ice to reduce free aldehyde groups, 
washed again in CB and transferred to the cryosectioning embedding 
mixture described by [6]: 20% polyvinyl pyrrolidone, 1.6 M sucrose in 
CB. After infiltration overnight, tissue pieces were mounted on cryo-
pins, frozen in liquid nitrogen and sectioned on a Reichert cryomi-
crotome (FC 4E, Leica, Vienna), at an approximate thickness of 0.15 
urn. Instead of using dry knives, sections were cut onto 40% DMSO 
[7] using a block temperature set at —60°C and a knife temperature 
set at —30°C. For glass knives, commercially available plastic boats 
(Leica, Vienna, Austria) were secured with superglue. Floating sec-
tions were transferred with a loop to a small, insulated reservoir 
(bottle cap) on the edge of the cryochamber containing a 1.2 M 
sucrose, 1% methylcellulose mixture [8] and then viewed under a dis-
secting microscope. Sections were retrieved with 4X4 mm coverslips 
coated with poly-L-lysine and stored floating in a petri dish containing 
87% glycerol. Prior to labelling the sections were washed to remove 
glycerol by transferring them through several drops of CB. 
2.2. Immunocytochemistry and microscopy 
The monoclonal antibody R4A to smoothelin has been described by 
van der Loop et al. [4]. Monospecific, polyclonal antibodies against 
desmin, myosin SI and filamin were as used previously [9-11]. Anti-
body labelling of coverslips involved the following steps: (a) preincu-
bation on a drop (10 JJ.1) of 2% normal goat serum, 1% bovine serum 
albumin (BSA, Sigma, Vienna) in Tris-buffered saline (TBS) contain-
ing 155 mM NaCl, 2 mM MgCl2, 2 mM EGTA, 20 mM Tris-base pH 
7.6 for 10-30 min; this and the subsequent antibody incubations were 
carried out on parafilm stretched over a glass plate mounted on moist 
filter paper in a 15 cm diameter plastic petri dish; (b) transfer to 10 ul 
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Fig. 1. Transverse ultrathin sections of chicken gizzard smooth muscle, double labelled for smoothehn (left panels) and myosin, desmin and fila-
min (right panels, as indicated). The smoothehn labelling pattern corresponds closely to that seen for desmin and filamin. For the lower row of 
photographs, sections were spread on TBS buffer, resulting in better separation of individual filaments. Bar, 5 um. 
of the primary antibody, also dissolved in 1% BSA in TBS and in-
cubation for 45-60 min at room temperature; (c) brief rinsing by 
floating on TBS (by consecutive transfer onto the surface of three 
10 (xl drops) followed by flotation on drops of TBS for 3 times 15 
min; (d) transfer to the secondary, conjugated antibody in 1% BSA in 
TBS on parafilm for 40 min to 1 h at room temperature; (e) rinsing 
and washing as described followed by mounting in Gelvatol (Vinol 
203, Air Products Inc., Allentown, PA, USA) with 2.5 mg/ml n-propyl 
gallate [12] added as antibleach agent. Fluorescent labelling was per-
formed using the biotin-streptavidin-FITC or Cy3-conjugated anti-
bodies supplied by Amersham International (Amersham, UK) or 
Texas Red-conjugated secondary antibodies (Vector Laboratories 
Inc., Burlingame, CA). For dual labelling, the individual antibody 
concentrations were titrated to give quantitatively similar intensities 
of label for the separate staining patterns. 
Semithin sections were evaluated using a Zeiss Axiovert 135TV 
inverted microscope equipped for epifluorescence microscopy, using 
a 100X/NA 1.3 Plan-Neofluar objective and up to 2.5 X optivar in-
termediate magnification. Fluorescence images were acquired and 
stored as 16-bit sequences using a back illuminated, cooled CCD 
camera from Princeton Instruments driven by IPLabs software 
(both from Visitron Systems, Eichenau, Germany) on a Macintosh 
Power PC7100/80. 
2.3. Extraction of muscle strips 
The muscle strips from freshly excised and ice-cooled chicken giz-
zard were cut into small pieces and homogenized sequentially in 40 ml 
of the following extraction buffers with intermediate centrifugation 
steps at 15000Xg for 10 min; (1) 0.5% Triton X-100 in CB; (2) 60 
mM KC1, 1 mM EDTA, 2 mM EGTA, ImM dithiothreitol (DDT), 
10 mM ATP, 40 mM imidazole, pH 7.1 (LAMES [13]); (3) LAMES 
plus 0.6 M NaCl; (4) LAMES; (5) 25 mM TRIS, 2 mM EDTA, 
2 mM EGTA, 0.1 mM dithioerythritol, 2.5% sucrose, pH 9.0 (low 
salt, high pH). Homogenization was performed with an Ultra-Turrax 
blender in a 50 ml centrifuge tube and was repeated twice in fresh 
extraction buffer for each step. Samples of the supernatants after the 
first homogenization and pellets after the second were taken at each 
step and processed for SDS gel electrophoresis, as described previ-
ously [14]. 
2.4. Immunoblotting and electrophoresis 
Freshly dissected pieces of either chicken aortic arch or jugular vein 
were frozen in liquid nitrogen, then shattered by hammering and dis-
solved in SDS-sample buffer [15]. Prior to gel electrophoresis, samples 
dissolved in sample buffer (0.05 M Tris-HCl, 0.03% glycerol, 0.01% |3-
mercaptoethanol, 10 mg/1 bromophenol blue and 2.2 g/1 SDS in 6 M 
urea) were boiled for 1 min to complete reaction with SDS. 
Electrophoresis was carried out on minislab gels as described by 
Gimona et al. [14] and the gels blotted onto nylon membrane sheets 
(Immobilon-p transfer membrane, Millipore, Vienna) according to 
[16]. Antibody reactions were visualized using either the peroxidase 
'Sigma Fast' system with a secondary peroxidase antibody from the 
chemiluminescence (ECL) kit from Amersham, or by the ECL method 
(Amersham, UK) according to the manufacturer's instructions. The 
monoclonal antibodies against calponin (CP-93), desmin (DU-10) and 
|3-actin (AC-15) were from Sigma and the rabbit polyclonal antibodies 
against filamin, myosin light chain and vinculin were as described 
previously [11,17]. The polyclonal anti-60 kDa protein antibody was 
kindly provided by Dr. Shohei Maekawa (Kyoto Institute of Tech-
nology, Japan). In the case of muscle extracts, blots were reacted 
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Fig. 2. Longitudinal ultrathin sections of chicken gizzard smooth muscle, double labelled for smoothelin (left panels) and myosin, desmin and 
filamin (right panels, as indicated). The fibrillar labelling pattern for smoothelin most closely resembles that for filamin. Bar, 5 um. 
simultaneously with two antibodies to facilitate comparison. The blots 
were scanned on a Mikrotek Scanmaker II SP and a composite blot 
created using Adobe Photoshop. 
For two dimensional gel electrophoresis total tissue samples were 
lysed in 9.8 M urea and soluble proteins separated on NEPHGE first 
dimension tube gels followed by second dimensions on 12.5% SDS 
PAGE mini slab gels as described earlier [15]). 
2.5. Immunoprecipitation 
Immunoprecipitations using chicken gizzard smooth muscle ex-
tracts were performed using protein A Sepharose beads as described 
[18] with the minor modifications indicated below. Briefly, 2 g of fresh 
chicken gizzard smooth muscle was homogenized in 25 ml buffer 
containing 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 2% (v/v) glyc-
erol, 0.25% (v/v) Triton X-100, 1 mM phenylmethylsulfonyl fluoride 
(PMSF), 1 mM EDTA (IP buffer) and left 30 min on ice. Cellular 
residues were removed by centrifugation at 15 000 X g. Prior to immu-
noprecipitation the supernatant was clarified by ultracentrifugation at 
100 000 Xg for 30 min and further cleared of non-specific reaction 
products by incubation for 60 min with protein A Sepharose (Phar-
macia, Vienna) in IP buffer. 
3. Results 
3.1. Smoothelin is localized in the cytoskeleton of gizzard 
smooth muscle cells 
In transverse ultrathin sections of gizzard muscle the 
smoothelin antibody produced a punctate pattern that co-dis-
tributed with that observed for desmin and filamin (Fig. 1). 
Both of these latter proteins are major components of the 
cytoskeleton domain of smooth muscle cells [19]. Smoothelin 
label contrasted with that for myosin, which is more generally 
distributed in the cell (Fig. 1), and defines the extent and 
localization of the contractile domain. Longitudinal sections 
revealed a fibrillar pattern for smoothelin that was again dif-
ferent from myosin (Fig. 2) and matched more closely that 
seen for filamin than for desmin (Fig. 2). 
3.2. Smoothelin is co-extracted with actin-binding proteins 
Although smoothelin immunostaining co-distributed with 
that for filamin, it also resembled the pattern obtained for 
desmin and a possible association of smoothelin with the in-
termediate filaments had thus to considered. It has formerly 
been shown that desmin is relatively insoluble and that the 
major part of desmin remains in the residue obtained after 
extraction of muscle cells with detergents and concentrated 
salt solutions [13]. By following the distribution of smoothelin 
in the pellet and supernatant fractions of a gizzard muscle 
homogenate extracted sequentially under different conditions, 
we could show that smoothelin does not co-fractionate with 
desmin. As can be seen in Fig. 3, smoothelin was readily 
extracted together with myosin, vinculin, filamin and (3-actin 
under conditions that do not solubilize desmin. This is most 
evident in lane 1 of Fig. 3, corresponding to protein extracted 
in Triton X-100. In connection with the immunoprecipitation 
experiments described below we found, additionally, that 
smoothelin was readily extracted from fresh gizzard muscle 
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at physiological ionic strength, also in the absence of Triton 
X-100. After the sequential extractions described above a frac-
tion of smoothelin was still retained in the pellet fractions, 
along with the residue of the other cytoskeletal and contractile 
proteins, presumably due to the incomplete homogenization 
of the tissue. 
3.3. Smoothelin is a minor protein that appears at a late stage 
of smooth muscle differentiation 
Immunoblots of two dimensional gels of chick gizzard iden-
tified smoothelin as a basic protein with a pi around 8.2 and a 
series of isoelectric variants (Fig. 4). In parallel gels stained 
with Coomassie blue the corresponding smoothelin spot was 
barely identified, being an order of magnitude smaller than 
those of calponin and SM22, that occur in the same pH range 
[15]. But the specificity and high affinity of the smoothelin 
antibody allowed us to follow the protein's expression during 
embryogenesis in the chick gizzard. As shown in Fig. 5B 
smoothelin was not detectable before embryonic day 18, 
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Fig. 3. Immunoblots of whole chicken gizzard homogenates (A) and 
of the supernatants obtained under different extraction conditions 
(B). Lanes 2-5 in A show immunoblots of the same chicken gizzard 
sample (see Coomassie blue stained gel, panel B, lane 6) labelled 
with the different pairs of antibodies to the antigens indicated on 
the left. B shows a composite immunoblot of the different superna-
tant fractions obtained during the different extraction steps as de-
scribed in Section 2. The original immunoblots of these superna-
tants after double antibody labelling (as in lane A) were scanned in 
Adobe Photoshop and edited into single lanes, for clarity. Hence 
the positions of proteins in the Coomassie lane 6 do not match. 
Lanes 1-5 correspond to the supernatants obtained after sequential 
extractions of the same sample using the conditions 1-5 given in 
Section 2. These were briefly: lane 1, Triton X-100 in CB; lane 2, 
ATP in low salt; lane 3, ATP in high salt; lane 4, ATP in low salt; 
lane 5, low salt, high pH. Note that smoothelin was not co-ex-
tracted with desmin but co-fractionated with the actin-associated 
proteins. Abbreviations; Fil, filamin; M-vin, metavinculin; vin, vin-






Fig. 4. Immunoblot of a two dimensional NEPHGE gel of total 
chicken gizzard smooth muscle extract probed with the R4A anti-
smoothelin antibody. Smoothelin (sm) appears as multiple isoelectric 
variants (vertical arrows) of similar molecular weight. The estimated 
pi values range from 8.9 to 7.9. The positions of other smooth 
muscle marker proteins were determined by Ponceau S stain of the 
nitrocellulose following transfer and are indicated: 1, actin; 2, tro-
pomyosin; 3, SM22; 4, calponin. Molecular weights in kDa. 
onic day 5 (Fig. 5A) [3]. In the last days of embryonic life 
smoothelin appeared as a doublet, the band of lower molec-
ular weight (Fig. 5B), being absent, or reduced in the adult. 
3.4. A high molecular weight isoform of smoothelin is expressed 
in vascular smooth muscle 
Avian vascular smooth muscle of both veins and arteries 
exhibited a single polypeptide with an apparent molecular 
weight of 95 kDa reactive in immunoblots with the smooth-
elin antibody (Fig. 5C). The same samples were equally pos-
itive for calponin (Fig. 5D). On the presumption that the high 
molecular weight band could be a dimer of the 59 kDa 
smoothelin protein, various strategies were employed to main-
tain the samples in a reduced state prior to electrophoresis. 
However, none of these, including the addition of high con-
centrations of dithioerythritol or p-mercaptoethanol, had any 
effect on the intensity of the 95 kDa band. We conclude there-
fore that the occurrence of this band may be indicative of a 
high molecular weight variant of smoothelin. Tmmunofiuores-
cence labelling by the smoothelin antibody in chicken blood 
vessels was restricted to the layers of smooth muscle in the 
vessel wall (not shown). 
3.5. Smoothelin is distinct from the 60 kDa filamin-binding 
protein 
Maekawa and Sakai [20] described a 60 kDa protein from 
smooth muscle that bound to filamin. In view of smoothelin's 
apparent molecular weight of 60 kDa and its co-localization 
with filamin it was relevant to establish whether or not 
smoothelin and the 60 kDa protein were identical. The results 
of two sets of experiments indicated that this was not the case. 
We first took advantage of the absence of the 59 kDa molec-
ular weight smoothelin in arterial smooth muscle. As shown 
in Fig. 6 the anti-60 kDa antibody labelled only a 60 kDa 
product in these vascular samples, in which the smoothelin 
antibody labelled only the 95 kDa band (Fig. 6). In a second 
experiment, smooth muscle extracts were subjected to immu-
noprecipitation with either the smoothelin or the 60 kDa anti-
body. Each antibody specifically precipitated only its respec-
tive antigen (Fig. 7). Thus, smoothelin is not the 60 kDa 
filamin-binding protein. 
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Embryonic gizzard (days) Vascular smooth muscle 
Fig. 5. A,B: Immunoblots of gizzard samples taken from chick embryos at embryonic days 16 and 18, at hatching (H) and from an adult 
chicken (A), made using the calponin and smoothelin antibodies. Note the late appearance of smoothelin (SM) at around 18 days, as compared 
to calponin (CaP) and the occurrence of a lower molecular weight, embryomc form (e SM). C,D: Vascular smooth muscle samples from adult 
chickens blotted with the smoothelin and calponin antibodies and showing the high molecular weight variant of smoothelin (vSM). Samples 
were: 1, jugular vein; 2, carotid artery; 3, ascending aorta. 
4. Discussion 
Studies on the localization of different smooth muscle pro-
teins have revealed a partitioning of contractile and structural 
proteins into complementary domains in the smooth muscle 
cell, i.e. the contractile domains and cytoskeletal domains [19]. 
Desmin containing intermediate filaments constitute a major 
component of the cytoskeleton domain. The contractile do-
main, responsible for the generation of mechanical forces in 
the muscle cells, mainly consists of actin and myosin. 
Although the presence of two domains within the smooth 
muscle cell is distinct, the filament systems that make them 
up appear to be integrated into a functional unit through 
mechanical coupling via the cc-actinin containing dense bodies 
[19]. 
Information about the binding partners of smoothelin is 
currently lacking. However, the noted homology of part of 
its primary sequence to the consensus actin binding domain 
of proteins of the spectrin family suggests that it could be 
actin associated [4]. We have earlier demonstrated that non-
muscle type actin is specifically localized in the cytoskeleton 
domain of smooth muscle cells, along with filamin and desmin 
[5]. Since smoothelin colocalizes with filamin in chicken giz-
zard cells we presume it is associated, like filamin, with the 
non-muscle actin component of the cytoskeleton. This conclu-
sion would be in line with the present extraction data, and 
with the observed co-localization of smoothelin with stress 
fibers in primary chicken culture cells as well as in cardiomyo-
cytes and certain smooth muscle cell lines [4]. Binding studies 
with purified smoothelin will, however, be necessary to sup-
port these conclusions. As we show, smoothelin is not related 
to the 60 kDa filamin-binding protein described by Maekawa 
and Sakai [20]. The lack of identity of the two proteins is also 
supported by the observed expression of the 60 kDa protein in 
heart and skeletal muscle [20], from which smoothelin is ab-
sent. 
The presence of the 95 kDa molecular weight form of 
smoothelin in vascular muscle is intriguing and potentially 
significant. We have not yet localized this isoform by high 
resolution immunocytochemistry in vascular muscle but pre-
sume that it is also associated with the cytoskeleton. Since a 
reduction in apparent molecular weight could not be achieved 
using reducing agents, the 95 kDa smoothelin does not appear 
to arise from a homo- or heterodimer species. The possibility 
that vascular and visceral smoothelin may be the product of 
different genes has been refuted since fluorescent in situ hy-
bridization experiments revealed only one signal on chromo-
some 22 (van Eys, personal communication), suggesting that 
the differences in molecular weight arise either from extensive 
post-translational modifications, from alternative splicing or 
from a dual promoter system. Current studies are aimed at 
establishing the origin of the vascular isoform of smoothelin. 
** Q £ 
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anti-smoothelin anti-60 kDa 
Fig. 6. A: Immunoblot of total homogenates from chicken gizzard 
and vascular smooth muscle samples (femoral vein, ascending aorta) 
with the smoothelin antibody showing the 95 kDa molecular weight 
isoform of smoothelin (vSM). B: The same samples as in A blotted 
with the antibody to the 60 kDa filamin-binding protein. In this 
case gizzard and vascular samples show only one band at 60 kDa. 
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represents a non-specific cross-reaction of the polyclonal anti-60 
kDa antiserum. SM and 60 kDa indicate the positions of smoothe-
lin and the 60 kDa filamin-binding protein. 
In conclusion, smoothelin is here identified as a minor com-
ponent of the smooth muscle cell cytoskeleton that is most 
likely associated with actin. More data on the biochemistry of 
smoothelin are required to establish its in vitro properties and 
its binding partners, as a necessary further step towards elu-
cidating its role in the smooth muscle cell. 
[1] Owens, G.K. (1995) Physiol. Rev. 75, 487-517. 
[2] Glukhova, M.A. and Koteliansky, V.E. (1995) in: The Vascular 
Smooth Muscle Cell. Molecular and Biological Responses to the 
Extracellular Matrix (S.M. Schwartz and R.P. Mecham, Eds.), 
pp. 37-79, Academic Press, New York. 
[3] Duband, J.-L., Gimona, M., Scatena, M., Sartore, S. and Small, 
J.V. (1993) Differentiation 55, 1-11. 
[4] van der Loop, F.T.L., Schaart, G., Timmer, E.D.J., Ramaekers, 
F.C.S. and Van Eys, G.J.J.M. (1996) J. Cell Biol. 134, 401^111. 
[5] North, A.J., Gimona, M., Lando, Z. and Small, J.V. (1994) 
J. Cell Sci. 107, 445^155. 
[6] Tokuyasu, K.T. (1989) Histochem. J. 21, 163-171. 
[7] Bernard, W. and Leduc, E.H. (1967) J. Cell Biol. 34, 757-771. 
[8] Liou, W. and Slot, W. (1994) ICEM 13, Paris, 17-22 July, 
pp. 253-254. 
[9] Ramaekers, F.C.S., Huijsmans, A., Schaart, G., Moesker, O. and 
Vooijs, G.P. (1987) in: Application of Monoclonal Antibodies in 
Tumor Pathology (D.J. Ruiter, G.J. Fleuren, and S.O. Warnaar, 
Eds.), pp. 65-85, Martinus Nijhoff, Dordrecht. 
[10] Langanger, G., Moeremans, M., Daneels, G., Sobieszek, A., De 
Brabander, M. and De Mey, J. (1986) J. Cell Biol. 102, 200-209. 
[11] Small, J.V., Filrst, D.O. and De Mey, J. (1986) J. Cell Biol. 102, 
210-220. 
[12] Giloh, H. and Sedat, J.W. (1992) Science 217, 1252-1255. 
[13] Small, J.V. and Sobieszek, A. (1977) J. Cell Sci 23, 243-268. 
[14] Gimona, M., Herzog, M., Vandekerckhove, J. and Small, J.V. 
(1990) FEBS Lett. 274, 159-162. 
[15] Gimona, M., Sparrow, M.P., Strasser, P., Herzog, M., and 
Small, J.V. (1992) Eur. J. Biochem. 205, 1067-1075. 
[16] Towbin, H., Staehelin, T. and Gordon, J. (1979) Proc. Natl. 
Acad. Sci. USA 76, 4350^1354. 
[17] North, A.J., Galazkiewicz, B., Byers, T.J., Glenney, J.R. and 
Small, J.V. (1993) J. Cell Biol. 120, 1159-1167. 
[18] Gimona, M., Watakabe, A. and Helfman, D.M. (1995) Proc. 
Natl. Acad. Sci. USA 92, 9776-9780. 
[19] Small, J.V. (1995) BioEssays 17, 785-792. 
[20] Maekawa, S. and Sakai, H. (1987) FEBS Lett. 221, 68-72. 
